TOKYO and SAN FRANCISCO, Sept. 18, 2023 /PRNewswire/ -- Astellas Venture Management LLC (President: William Watt, Ph.D., "AVM"), a wholly owned venture capital subsidiary of Astellas Pharma Inc ...

"However, when Astellas Venture Management and Montage Ventures approached us, it was clear that they could add significant strategic value. Astellas Pharma and Astellas Institute for Regenerative ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include ...

Joint venture will aim to develop a cell ... looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light ...